Bronchopulmonary Dysplasia and Ureaplasma: What Do We Know So Far?
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Bronchopulmonary dysplasia (BPD) is the most common morbidity of prematurity. BPD is a chronic respiratory disease related to lung-injury during the primary course of critical lung disease such as respiratory distress syndrome or when abnormal development of the preterm lung occurs. Abnormal lung development not only results from primary lung injury in the first days after birth, but also secondary injury through abnormal repair resulting in arrested and abnormal alveolarization, fibrosis and pulmonary vascular dysgenesis. Chorioamnionitis is a risk factor that plays an important role in the development of BPD. Ureaplasma subspecies (spp.) are the most common isolated organisms from chorioamniotic tissue after premature births. Therefore Ureaplasma spp. appear to play an important role in the development of BPD, and treatment or prophylactic treatment of these infections or colonization may reduce the incidence, morbidity and mortality of BPD. Ureaplasma spp. infections are challenging not only to treat, but also to diagnosis in a timely manner. This review summarizes the current state of treatment and new developments in the treatment of Ureaplasma exposure in premature infants.
Abstract
Bronchopulmonary dysplasia (BPD) is the most common morbidity of prematurity. BPD is a chronic respiratory disease related to lung-injury during the primary course of critical lung disease such as respiratory distress syndrome or when abnormal development of the preterm lung occurs. Abnormal lung development not only results from primary lung injury in the first days after birth, but also secondary injury through abnormal repair resulting in arrested and abnormal alveolarization, fibrosis and pulmonary vascular dysgenesis. Chorioamnionitis is a risk factor that plays an important role in the development of BPD. Ureaplasma subspecies (spp.) are the most common isolated organisms from chorioamniotic tissue after premature births. Therefore Ureaplasma spp. appear to play an important role in the development of BPD, and treatment or prophylactic treatment of these infections or colonization may reduce the incidence, morbidity and mortality of BPD. Ureaplasma spp. infections are challenging not only to treat, but also to diagnosis in a timely manner. This review summarizes the current state of treatment and new developments in the treatment of Ureaplasma exposure in premature infants.
참고문헌 (32)
- Poindexter BB, "Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program", Ann Am Thorac Soc, 12, pp.1822~1830 (2015)
- Northway WH Jr., "Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia", N Engl J Med, 276, pp.357~368 (1967)
- Hütten MC, "Can the preterm lung recover from perinatal stress?", Mol Cell Pediatr, 3, pp.15~ (2016)
- Ehrenkranz RA, "Validation of the National Institute of Health consensus definition of bronchopulmonary dysplasia", Pediatrics, 116, pp.1353~1360 (2005)
- Schmidt B, "Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely lowbirth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms", JAMA, 289, pp.1124~1129 (2003)
- Kotecha S, "Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants", Pediatr Res, 55, pp.61~68 (2004)
- Nair V, "Azithromycin and other macrolides for prevention of bronchopulmonary dysplasia: a systematic review and meta-analysis", Neonatology, 106, pp.337~347 (2014)
- Moss TJ, "Experimental amniotic fluid infection in sheep: effects of Ureaplasma parvum serovars 3 and 6 on preterm or term fetal sheep", Am J Obstet Gynecol, 198, pp.122~ (2008)
- Wang EE, "Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity:results of a meta-analysis", J Pediatr, 127, pp.640~644 (1995)
- Sung TJ, "Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia", Pediatr Infect Dis J, 30, pp.379~383 (2011)
- Schelonka RL, "Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques", Pediatr Infect Dis J, 24, pp.1033~1039 (2005)
- Viscardi RM, "Role of Ureaplasma respiratory tract colonization in bronchopulmonary dysplasia pathogenesis. Current concepts and update", Clin Perinatol, 42, pp.719~738 (2015)
- Lowe J, "Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preterm infants. Updated systematic review and meta-analysis", Pediatr Infect Dis J, 33, pp.697~702 (2014)
- Jonsson B, "Ureaplasma urealyticum, erythromycin and respiratory morbidity in high risk preterm neonates", Acta Pediatr, 87, pp.1079~1084 (1998)
- Olomu IN, "Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation", Pediatrics, 123, pp.1329~1336 (2009)
- Katz B, "Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia", J Clin Microbiol, 43, pp.4852~4854 (2005)
- Li YH, "Ureaplasma urealyticum-induced production of proinflammatory cytokines by macrophages", Pediatr Res, 48, pp.114~119 (2000)
- Li YH, "Ureaplasma urealyticum induces apoptosis in human lung epithelial cells and macrophages", Biol Neonate, 82, pp.166~173 (2002)
- Kallapur SG, "Ureaplasma and BPD", Semin Perinatol, 37, pp.94~101 (2013)
- Okogbule-Wonodi AC, "Surfactant protein-A enhances ureaplasmacidal activity in vitro", Innate Immun, 17, pp.145~151 (2011)
- Cultrera R, "Molecular evidence of Ureaplasma urealyticum and Ureaplasma parvum colonization in preterm infants during respiratory distress syndrome", BMC Infect Dis, 6, pp.166~ (2006)
- Kim SM, "Gastric fluid versus amniotic fluid analysis for the identification of intra-amniotic infection due to Ureaplasma species", J Matern Fetal Neonatal Med, 29, pp.2579~2587 (2016)
- Mabanta CG, "Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum", Cochrane Database Syst Rev, pp.CD003744~ (2003)[DOI]
- Krausse R, "In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years", Clin Microbiol Infect, 16, pp.1649~1655 (2010)
- Ozdemir R, "Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants", Pediatrics, 128, pp.e1496~e1501 (2011)
- Ballard HO, "Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial", Pediatr Pulmonol, 46, pp.111~118 (2011)
- Hassan HE, "Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia", J Clin Pharmacol, 51, pp.1264~1275 (2011)
- Merchan LM, "Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization", Antimicrob Agents Chemother, 59, pp.570~578 (2015)
- Resch B, "Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics", Infection, 44, pp.323~327 (2016)
- Miura Y, "Maternal intravenous treatment with either azithromycin or solithromycin clears Ureaplasma parvum from the amniotic fluid in an ovine model of intrauterine infection", Antimicrob Agents Chemother, 58, pp.5413~5420 (2014)
- Furfaro LL, "In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin", Int J Antimicrob Agents, 46, pp.319~324 (2015)
- Garcia-Castillo M, "Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates", J Antimicrob Chemother, 62, pp.1027~1030 (2008)